PLIANT THERAPEUTICS INC (PLRX)

US7291391057 - Common Stock

11.44  -0.33 (-2.8%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.001.58M9.69M7.57M41.82M
Operating Expenses
222.08M185.72M136.89M105.11M83.46M
Research and Development
163.70M127.80M96.94M77.55M66.19M
Selling, General, and Administrative Expenses
58.38M57.93M39.95M27.56M17.27M
Operating Income
-222.08M-184.15M-127.20M-97.54M-41.65M
Interest Income/Expense
20.40M22.81M3.88M270.00K480.00K
Other Income/Expense
N/AN/AN/AN/A-370.00K
Income Before Taxes
-201.68M-161.34M-123.32M-97.26M-41.53M
Net Income
-201.68M-161.34M-123.32M-97.26M-41.53M
EBITDA
-219.95M-182.30M-125.38M-96.00M-40.34M
 
Per Share Data
EPS Diluted Total Ops
-3.34-2.75-2.94-2.71-1.95
Non GAAP EPS
-3.34-2.76-2.97-2.71N/A
 
Statistics
Profit Margin
N/A-10211.14%-1272.65%-1284.81%-99.31%
Operating Profit Margin
N/A-11654.75%-1312.69%-1288.51%-99.59%

All data in USD

Charts